ABSTRACT
COV-19 has been quickly spreading in the world, producing lung inflammation and abrupt, even deadly, pulmonary collapse, COV-19were much higher in diabetic patients than in non-diabetic pa-tients. Diabetes is one of the primary causes of illness and death, and its prevalence is projected to increase rapidly over the next several decades. This investigation sought to determine how COVID-19 influenced the levels of glucose in the blood of patients diagnosed with type 1 and type 2 diabetes (DM), as well as whether or not the levels of glucose returned to normal following a recovery period of one month. Addi-tionally, there was a connection between ABO blood type and the severity of COV-19. The current study was to how COV-19 affected ABO group distribution and blood glucose levels in people who suffer from type 1 and 2 diabetes (DM). Study design: This study included ninety (90) patient divided into three groups: diabetes patient group (30) sample (control), 30 sample of DM with COV-19group and 30 sample recovery from Covid 19 after period one month of recovery, determination of the above mentioned blood groups was performed using manual method, and glucose levels measured of DM by diabetes device. The study demonstrated a relation between blood type ABO and COV-19, with type B blood being the most influenced by COV-19 in patients with type 2 diabetes, whereas there were no significant variations between blood types in those who suffer from type 1 diabetes. In type 1, 2 diabetic patients, no significant differences in blood glucose levels were found between diabetic patients with COV-19 and the recovery group from COV-19. The study displayed that the severity of COV-19 disease associated with B blood type in patients who suffer from type 2 diabetes and Cov-19 has no direct impact on blood glucose levels.Copyright © 2023, Colegio de Farmaceuticos de la Provincia de Buenos Aires. All rights reserved.